Reshape Lifesciences Inc (RSLS)
0.1764
+0.01
(+4.94%)
USD |
NASDAQ |
Apr 25, 16:00
0.178
0.00 (0.00%)
After-Hours: 20:00
Reshape Lifesciences Free Cash Flow: -17.00M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -17.00M |
September 30, 2023 | -17.45M |
June 30, 2023 | -19.98M |
March 31, 2023 | -19.72M |
December 31, 2022 | -22.03M |
September 30, 2022 | -22.62M |
June 30, 2022 | -25.20M |
March 31, 2022 | -21.03M |
December 31, 2021 | -15.73M |
September 30, 2021 | -14.16M |
June 30, 2021 | -7.391M |
March 31, 2021 | -7.775M |
December 31, 2020 | -8.94M |
September 30, 2020 | -8.339M |
June 30, 2020 | -11.50M |
March 31, 2020 | -11.75M |
December 31, 2019 | -14.20M |
September 30, 2019 | -20.01M |
June 30, 2019 | -20.31M |
March 31, 2019 | -23.92M |
December 31, 2018 | -27.54M |
September 30, 2018 | -29.30M |
June 30, 2018 | -30.46M |
March 31, 2018 | -29.60M |
December 31, 2017 | -24.73M |
Date | Value |
---|---|
September 30, 2017 | -19.37M |
June 30, 2017 | -18.26M |
March 31, 2017 | -18.20M |
December 31, 2016 | -20.67M |
September 30, 2016 | -22.50M |
June 30, 2016 | -23.90M |
March 31, 2016 | -23.92M |
December 31, 2015 | -22.64M |
September 30, 2015 | -21.77M |
June 30, 2015 | -20.13M |
March 31, 2015 | -19.50M |
December 31, 2014 | -19.47M |
September 30, 2014 | -19.30M |
June 30, 2014 | -19.18M |
March 31, 2014 | -19.47M |
December 31, 2013 | -18.84M |
September 30, 2013 | -20.03M |
June 30, 2013 | -20.23M |
March 31, 2013 | -20.11M |
December 31, 2012 | -22.56M |
September 30, 2012 | -22.47M |
June 30, 2012 | -23.20M |
March 31, 2012 | -22.81M |
December 31, 2011 | -20.19M |
September 30, 2011 | -18.30M |
Free Cash Flow Range, Past 5 Years
-25.20M
Minimum
Jun 2022
-7.391M
Maximum
Jun 2021
-16.06M
Average
-17.00M
Median
Dec 2023
Free Cash Flow Benchmarks
Cutera Inc | -160.13M |
Dynatronics Corp | -1.735M |
Stereotaxis Inc | -9.505M |
Electromed Inc | 3.653M |
Myomo Inc | -6.319M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -2.457M |
Cash from Financing (Quarterly) | 5.461M |
Free Cash Flow Per Share (Quarterly) | -0.1047 |
Free Cash Flow to Equity (Quarterly) | -2.457M |
Free Cash Flow to Firm (Quarterly) | -2.457M |
Free Cash Flow Yield | -1.21K% |